HIV-1 infection | West Indian Medical Journal

Online Systems

Student Services

Registration & Fees

Online Support

Password Self Service

HIV-1 infection

A Reduction Grade of Lipodystrophy and Limited Side Effects after HAART Regimen with Raltegravir, Lamivudine, Darunavir and Ritonavir in an HIV-1 Infected Patient after Six Years of Antiretroviral Therapy

Issue:

Vol 64, Issue 3: June (2015)

DOI:

10.7727/wimj.2014.066

Pages:

291–3

ABSTRACT

Received:

12 Mar, 2014

Accepted:

14 Apr, 2015

PDF Attachment:

wimjjun2015_291_293.pdf

Journal Sections:

Keywords:

HIV-1 infection

severe lipodystrophy

Journal Authors:

e-Published: 14 Jul, 2015

Read more about A Reduction Grade of Lipodystrophy and Limited Side Effects after HAART Regimen with Raltegravir, Lamivudine, Darunavir and Ritonavir in an HIV-1 Infected Patient after Six Years of Antiretroviral Therapy

Long-term Maraviroc Therapy and Limited Side Effects in an HIV-1 Experienced Patient: Six Years of Antiretroviral Observation

Issue:

Vol 63, Issue 7: Dec (2014)

DOI:

10.7727/wimj.2014.068

Pages:

785–7

INTRODUCTION

Maraviroc, originally designated UK-427857, is a small molecule and the first oral antiretroviral drug in the CCR5 receptor antagonist class used in the treatment of HIV infection. This drug, classed as an entry inhibitor, was developed by the drug company Pfizer in its United Kingdom laboratory located in Sandwich.

Received:

12 Mar, 2014

Accepted:

27 Mar, 2014

PDF Attachment:

wimjdec2014_785_787.pdf

Journal Sections:

Keywords:

HIV-1 infection

limited side effects

long-term Maraviroc observation

Journal Authors:

e-Published: 29 Aug, 2014

Read more about Long-term Maraviroc Therapy and Limited Side Effects in an HIV-1 Experienced Patient: Six Years of Antiretroviral Observation

West Indian Medical Journal

Faculty of Medical Sciences,
The University of the West Indies,
Mona, Kingston 7
Tel: (876) 927-1214
Fax: (876) 927-1846
wimj@uwimona.edu.jm

Top of Page